Therapeutic Potential and Delivery Approaches of Algal Polysaccharides
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (30 June 2021) | Viewed by 4261
Special Issue Editor
Interests: marine biotechnology; algal biorefinery; water and seawater treatment; separation and extraction processes; isolation of bioactive molecules; nutraceuticals and cosmeceuticals
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Marine algae, unlike terrestrial plants, produce sulfated polysaccharides which are the main compounds of their extracellular matrix. For a long time, these complex sugars have been used in particular in the food industry. But these polysaccharides and their derived oligosaccharides produced by blue biotechnology also have promising biological properties such as anti-cancer, antimicrobial, anticoagulant, antioxidant, immunomodulator, etc.
Thus, in a viral pandemic context, different teams evaluated (in vitro) fucoidans extracted from Saccharina japonica to inhibit Covid-19. Some other studies conducted on mouse model suggest that all compounds can be used in nasal sprays, inhalers or oral doses. This is an easier way to deliver a drug, compared to the more technical intraveinous injection. But the mechanisms involved have to be precisely explained and validated.
In addition to their therapeutic potential, sulfated polysaccharides contribute to human health and well-being through nutraceuticals and cosmeceuticals. The application fields of sulfated polysaccharides even extend to plant and animal health. Papers allowing advances on these topics are welcome.
The aim of this Special Issue is to present the most recent works on the biomedical applications (including biological activities, mechanisms of action, analysis, extraction) of algal polysaccharides and their delivery approaches.
Dr. Laurent Vandanjon
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Sulfated polysaccharides
- Marine algae
- Biomedical applications
- Cosmetics
- Nutraceutics
- Drug delivery
